🔗 Share this article

Chancellor Reeves has revealed she is planning "focused steps to address cost of living challenges" in next month's financial statement.

During an interview with media outlets, she stated that curbing price rises is a joint responsibility of both the government and the Bank of England.

The United Kingdom's price growth is projected to be the most elevated among the G7 developed nations this calendar year and the following year.

Potential Utility Bill Measures

Reports indicate the government could take action to reduce energy bills, such as by reducing the present 5% level of VAT applied on energy supplies.

Another possibility is to reduce some of the policy costs presently added to household expenses.

Budgetary Constraints and Analyst Predictions

The administration will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for such measures.

The view from most economists is that Reeves will have to announce higher taxes or spending cuts in order to fulfill her voluntary debt limits.

Previously on Thursday, estimates indicated there was a twenty-two billion pound gap for the chancellor to fill, which is at the lower end of projections.

"There's a joint task between the central bank and the administration to bear down further on some of the drivers of price increases," Reeves told the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Revenue Commitments and International Issues

While a great deal of the attention has been on expected tax increases, the chancellor said the latest figures from the OBR had not altered her pledge to manifesto promises not to increase tax levels on income tax, sales tax or National Insurance.

She attributed an "unpredictable world" with growing international and trade issues for the Budget revenue measures, probably to be targeted on those "wealthiest."

Global Economic Disputes

Addressing apprehensions about the UK's economic relations with China she said: "The UK's security interests invariably come first."

Recent announcement by Chinese authorities to tighten trade restrictions on rare earths and other materials that are crucial for advanced tech manufacturing led US President the US President to propose an extra 100% tariff on imports from the Asian country, raising the possibility of an full-scale trade war between the two economic giants.

The American finance chief labeled the Chinese decision "economic coercion" and "a global supply chain power grab."

Asked about considering the US offer to join its conflict with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "harmful for the world economy and creates additional headwinds."

"In my view there are sectors where we need to challenge Chinese policies, but there are also significant prospects to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to achieve that balance correct."

The chancellor also stated she was working with other major economies "on our own critical minerals strategy, so that we are more independent."

Health Service Drug Costs and Investment

The Chancellor also admitted that the cost the National Health Service pays for pharmaceuticals could rise as a consequence of current negotiations with the US government and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping operations in the UK, with several attributing the modest returns they are getting.

Recently, the Science Minister said the cost the NHS spends on medicines would must rise to prevent companies and pharmaceutical investment departing from the United Kingdom.

Reeves told the BBC: "It has been observed because of the cost structure, that drug testing, innovative medicines have not been available in the United Kingdom in the manner that they are in other continental states."

"The objective is to ensure that people receiving treatment from the NHS are can access the top essential medicines in the world. And so we are examining all of that, and... seeking to secure more funding into the UK."